Trastuzumab-containing regimens for metastatic breast cancer
Trastuzumab has been recognised as an effective therapy for women with HER2 positive breast cancer for several years, and a Cochrane Review on the effects for women with early stage disease was published in 2012. This was joined in June 2014 by a review of the drug’s effects for more advanced cancer. Sara Balduzzi from the University of Modena and Reggio Emilia in Italy describes these findings.
Source: Podcasts from The Cochrane Library - Category: Journals (General) Authors: The Cochrane Collaboration Tags: Issue 4 to 6, April to June 2014 Source Type: podcasts
More News: Breast Cancer | Cancer | Cancer & Oncology | Databases & Libraries | General Medicine | HER2 | Herceptin | Podcasts | Women